🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine age-adjusted reference values of the visuALL Field Analyzer (v...
Status
Completed
Location
Wills Eye Hospital
Start Date
2019-01-08
Trial ID
NCT03804684
Treatments Being Tested
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to conti...
Status
Terminated
Location
Contact Alcon Call Center for Trial Locations
Start Date
2024-11-15
Trial ID
NCT06408649
Treatments Being Tested
Background and Rationale: LASIK has been among the highest satisfaction ra...
Status
Completed
Location
Kasr Alainy
Start Date
2018-08-15
Trial ID
NCT03597906
The goal of this research study is to evaluate the safety and tolerability ...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2023-04-21
Trial ID
NCT05701488
Treatments Being Tested
To study the effective lens position concept in second eye refinement (SER)...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02423668
Treatments Being Tested
The purpose of this study is to investigate the front surface wettability o...
Status
Completed
Location
Centre for Contact Lens Research: University of Waterloo
Start Date
2009-10
Trial ID
NCT01010555
Treatments Being Tested
This project is a multi-center, randomized, parallel-controlled, non-inferi...
Status
Completed
Location
Tianjin Eye Hospital
Start Date
2018-11-25
Trial ID
NCT04299243
Treatments Being Tested
The investigators aimed to confirm the efficacy and safety of transdermal p...
Status
Completed
Location
Gangdong Sacred Heart Hospital, Hallym Univ
Start Date
2016-12-02
Trial ID
NCT03153735
Treatments Being Tested
Bladder cancer is a common malignant tumor of the urinary system, radical r...
Status
Recruiting
Location
Zhujiang Hospital
Start Date
2018-05-02
Trial ID
NCT03108196
Glaucoma is the leading cause of irreversible blindness worldwide. Although...
Status
Unknown
Location
Multiple Locations
Start Date
2022-05-01
Trial ID
NCT05352854
Treatments Being Tested